Failure definition–dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?-Reference-Cited by-同舟云学术

Failure definition–dependent differences in outcome following radiation for localized prostate cancer: Can one size fit all?

Published:2005-02 Issue:2 Volume:61 Page:409-414
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kuban Deborah,Thames Howard,Levy Larry,Horwitz Eric,Kupelian Patrick,Martinez Alvaro,Michalski Jeff,Pisansky Thomas,Sandler Howard,Shipley William,Zelefsky Michael,Zietman Anthony

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference12 articles.

1. Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era;Kuban;Int J Radiat Oncol Biol Phys,2003

2. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995;Thames;Int J Radiat Oncol Biol Phys,2003

3. A standard definition of disease freedom is needed for prostate cancer;Critz;J Urol,2002

4. Defining prostate specific antigen progression after radical prostatectomy;Amling;J Urol,2001

5. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology Criteria;Gretzer;J Urol,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions;Prostate International;2019-06

2. Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy;Journal of Contemporary Brachytherapy;2017

3. Velocity and doubling time of prostate-specific antigen: mathematics can matter;Journal of Investigative Medicine;2016-01-14

4. Prostate Cancer;Clinical Radiation Oncology;2016

5. Biochemical Recurrence: A Valuable Endpoint?;Radiotherapy in Prostate Cancer;2013